The FDA has granted accelerated approval of Wegovy® (semaglutide) for adults with moderate to advanced metabolic ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Stocks soared on Friday after Federal Reserve Chair Jerome Powell signaled the central bank may be ready to resume cutting ...

Imagine losing weight effortlessly! Chinese scientists have developed flavorless, fat-trapping microbeads made from green tea ...

Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...

The Wall Street firm says current spending plans for AI should create some $920 billion in new value. That’s good news for ...

GLP-1 drugs were also associated with a slight increase in risk for kidney cancer. The increase was not statistically ...